13D Filing: Kearny Venture Partners LP Files on Akebia Therapeutics, Inc. (AKBA)

Page 2 of 10

Page 2 of 10 SEC Filing

CUSIP NO. 00972D105 13D/A Page 2 of 10
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (Entities Only).

Kearny Venture Partners, L.P. (“KVP”)

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)     ¨     (b)     x

3 SEC USE ONLY
4 SOURCE OF FUNDS WC
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ¨
6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON
WITH
7

SOLE VOTING POWER

1,529,120 shares, except that Kearny Venture Associates, L.L.C.
(“KVA”), the general partner of KVP, may be deemed to have sole voting power, and Caley Castelein (“Castelein”),
Richard Spalding (“Spalding”) and James Shapiro (“Shapiro”), the managing members of KVA, may be deemed
to have shared power to vote these shares.

8

SHARED VOTING POWER

See response to row 7.

9

SOLE DISPOSITIVE POWER

1,529,120 shares, except that KVA, the general partner of KVP,
may be deemed to have sole dispositive power, and Castelein, Spalding and Shapiro, the managing members of KVA, may be deemed to
have shared power to dispose of these shares.

10

SHARED DISPOSITIVE POWER

See response to row 9.

11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,529,120
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) ¨
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.0%
14 TYPE OF REPORTING PERSON (See Instructions) PN

Follow Akebia Therapeutics Inc. (NASDAQ:AKBA)













Page 2 of 10